This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Sinovac Biotech Ltd (SVA)

NASDAQ: Health Care

Company Balance Sheet
Dec 2015 Dec 2014 Dec 2013 Dec 2012
Assets
Cash and Equivalents 63.83M 91.52M 107.24M 91.24M
Receivables 39.02M 40.76M 31.93M 23.44M
Inventories 18.68M 18.83M 14.33M 10.53M
Other Current Assets 1.80M 0.00 0.00 0.00
Total Current Assets 128.52M 154.80M 157.25M 126.28M
Property, Plant & Equipment, Gross 100.86M 102.82M 95.42M 101.13M
Accumulated Depreciation & Depletion 36.91M 34.40M 27.46M 21.05M
Property, Plant & Equipment, Net 63.94M 68.42M 67.96M 80.08M
Intangibles 0.00 352.00K 772.00K 1.15M
Other Non-Current Assets 9.93M 14.44M 14.59M 801.74K
Total Non-Current Assets 74.46M 83.73M 83.44M 82.48M
Liabilities & Shareholder Equity
Total Assets 202.98M 238.53M 240.69M 208.76M
Accounts Payable 12.20M 14.16M 17.07M 15.24M
Short Term Debt 24.25M 49.97M 19.54M 3.33M
Other Current Liabilities 2.57M 2.37M 3.00M 2.69M
Total Current Liabilities 58.00M 79.83M 49.16M 30.15M
Long Term Debt 756.00K 1.80M 32.15M 31.18M
Deferred Income Taxes 0.00 0.00 0.00 4.07M
Other Non-Current Liabilities 5.49M 15.17M 15.75M 13.92M
Minority Interest 861.00K 515.00K 2.93M -3.90M
Total Non-Current Liabilities 21.70M 32.13M 62.85M 60.88M
Total Liabilities 79.70M 111.97M 112.01M 91.04M
Preferred Stock Equity 0.00 0.00 0.00 0.00
Common Stock Equity 123.28M 126.56M 128.68M 117.72M
Common Par 57.00K 56.00K 56.00K 55.09K
Additional Paid In Capital 109.94M 108.24M 107.39M 106.25M
Cumulative Translation Adjustment 0.00 0.00 0.00 0.00
Retained Earnings -8.28M -6.38M -4.71M -12.16M
Treasury Stock 0.00 0.00 0.00 0.00
Other Equity Adjustments 21.56M 24.65M 25.95M 23.58M
Total Capitalization 124.04M 128.37M 160.83M 148.91M
Total Equity 123.28M 126.56M 128.68M 117.72M
Total Liabilities & Stock Equity 202.98M 238.53M 240.69M 208.76M
Total Common Shares Outstanding 56.91M 55.81M 55.57M 55.09M
Preferred Shares 0.00 0.00 0.00 0.00
Treasury Shares 0.00 0.00 0.00 0.00
Basic Weighted Shares Outstanding 56.31M 55.68M 55.30M 54.93M
Diluted Weighted Shares Outstanding 56.31M 55.68M 55.80M 54.93M
Number of Employees 646 556 715 652
Number of Part-Time Employees 111 112 0 0
SVA News

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free

SVA Sinovac Biotech Ltd

Chart of SVA

Analysts Ratings for SVA

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 0 0 0 0
Moderate Buy 0 0 0 0
Hold 0 0 1 1
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
GET SVA ANALYST REPORT

SVA Chatter

Top Rated Stocks Top Rated Funds Top Rated ETFs